Biomagnetics Diagnostics Licences Los Alamos Biosensor IP
Posted: December 4, 2009
Biomagnetics Diagnostics Corp. has acquired additional intellectual property rights from Los Alamos National Security. The company intends to utilize this intellectual property for the development of a revolutionary integrated optical biosensor capable of screening blood donors for HIV/AIDS, hepatitis and tuberculosis in a single test at the point of collection.
The technology, originally developed at Los Alamos National Laboratory is for the quantitative multiplex detection of pathogen biomarkers and is protected through a U.S. patent application filed in October 2009. When utilized with the Integrated Optical Biosensor System licensed by the company from Los Alamos National Security, this technology is capable of detecting multiple pathogens from a single blood sample. Importantly, Biomagnetics Diagnostics plans to integrate these technologies into a handheld blood diagnostic device that can be utilized by relatively unskilled personnel to screen potential blood donors for various pathogens at the point of collection.
The company recently announced on November 30 that it has finalized a patent license agreement with Los Alamos National Security. Under the agreement, Biomagnetics will have access to the triggered optical biosensor and integrated optical biosensor system technology developed at Los Alamos National Laboratory.